Abstract
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders with poorly understood etiology that are defined exclusively on the basis of behavioral observations. This disorder has been linked to increased levels of oxidative stress and lower antioxidant capacity. Oxidative stress in autism has been studied at the membrane level and also by measuring products of lipid peroxidation, detoxifying agents (such as glutathione), and antioxidants involved in the defense system against reactive oxygen species (ROS). Several studies have suggested alterations in the activities of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, and catalase in autism. Additionally, altered glutathione levels and homocysteine/methionine metabolism, increased inflammation, excitotoxicity, as well as mitochondrial and immune dysfunction have been suggested in autism. Moreover, environmental and genetic risk factors may intensify vulnerability to oxidative stress in autism. Collectively, these studies suggest increased oxidative stress in autism that may contribute to the development of this disease both in terms of pathogenesis and clinical symptoms. Antioxidant supplementation, or ways to improve the altered metabolite levels in the interconnected transmethylation and transsulfuration pathways, has been associated with decreased autistic behaviors and severity. This chapter provides a conceptual framework on oxidative stress and antioxidants utility. These types of interventions should be further studied in order to determine their effectiveness at improving metabolic imbalances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lopez-Alarcona, C., & Denicola, A. (2013). Evaluating the antioxidant capacity of natural products: A review on chemical and cellular-based assays. Analytica Chimica Acta, 763, 1–10.
Sies, H. (1985). Oxidative stress: Introductory remarks. London: Academic Press.
Poljsak, B., Suput, D., & Milisav, I. (2013). Achieving the balance between ROS and antioxidants: When to use the synthetic antioxidants. Oxidative Medicine and Cellular Longevity, 2013, 956792.
Koopman, W. J., Nijtmans, L. G., Dieteren, C. E., Roestenberg, P., Valsecchi, F., Smeitink, J. A. M., et al. (2010). Mammalian mitochondrial complex I: Biogenesis, regulation, and reactive oxygen species generation. Antioxidants & Redox Signaling, 12, 1431–1470.
Kohen, R., & Nyska, A. (2002). Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology, 30, 620–650.
Gutteridge, J. M. C. (1994). Biological origin of free radicals, and mechanisms of antioxidant protection. Chemico-Biological Interactions, 91, 133–140.
Berlett, B. S., & Stadtman, E. R. (1997). Protein oxidation in aging, disease, and oxidative stress. The Journal of Biological Chemistry, 272, 20313–20316.
Poulsen, H. E., Specht, E., Broedbaek, K., Henriksen, T., Ellervik, C., MandrupPoulsen, T., et al. (2012). RNA modifications by oxidation: A novel disease mechanism. Free Radical Biology & Medicine, 52, 1353–1361.
Yamamoto, H., Ozaki, T., Nakanishi, M., Kikuchi, H., Yoshida, K., Horie, H., et al. (2007). Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation. Genes to Cells, 12, 461–471.
Chu, F. F., Doroshow, J. H., & Esworthy, R. S. (1993). Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. The Journal of Biological Chemistry, 268, 2571–2576.
El-Agamey, A., Lowe, G. M., McGarvey, D. J., Mortensen, A., Phillip, D. M., Truscott, T. G., et al. (2004). Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys, 430(1), 37–48.
Rose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., et al. (2012). Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Translational Psychiatry, 2(7), 134.
James, S. J., Melnyk, S., Jernigan, S., Pavliv, O., Trusty, T., Lehman, S., et al. (2010). A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153(6), 1209–1220.
Xie, W., Ge, X., Li, L., Yao, A., Wang, X., Li, M., et al. (2018). Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERß activation. Molecular Autism, 2, 9–43.
Hamzawy, M. A., El-Ghandour, Y. B., Abdel-Aziem, S. H., & Ali, Z. H. (2018). Leptin and camel milk abate oxidative stress status, genotoxicity induced in valproic acid rat model of autism. International Journal of Immunopathology and Pharmacology, 32, 2058738418785514.
Khalaj, R., Hajizadeh Moghaddam, A., & Zare, M. (2018). Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism. International Journal of Developmental Neuroscience, 69, 80–87.
Frandsen, J. R., & Narayanasamy, P. (2018). Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway. Redox Biology, 14, 465–473.
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alzahrani, M. Z., Alshammari, M. A., et al. (2018). Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T+ Itpr3tf/J autistic mice. European Journal of Pharmacology, 829, 70–78.
Ahmad, S. F., Ansari, M. A., Nadeem, A., Alzahrani, M. Z., Bakheet, S. A., & Attia, S. M. (2018). Resveratrol improves neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and COX-2 signaling in BTBR T+ Itpr3tf/J mice. Neuromolecular Medicine, 20(1), 133–146.
Rani, V., Gautam, S., Rawat, J. K., Singh, M., Devi, U., Yadav, R. K., et al. (2018). Effects of minocycline and doxycycline against terbutaline induced early postnatal autistic changes in albino rats. Physiology & Behavior, 183, 49–56.
Zhang, Y., Cui, W., Zhai, Q., Zhang, T., & Wen, X. (2017). N-acetylcysteine ameliorates repetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism. Molecular Medicine Reports, 16(2), 2233–2240.
Dominiak, A., Wilkaniec, A., Jesko, H., Czapski, G. A., Lenkiewicz, A. M., Kurek, E., et al. (2017). Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain. Neurochemistry International, 108, 66–77.
Bhandari, R., & Kuhad, A. (2017). Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochemistry International, 103, 8–23.
Gao, J., Wang, X., Sun, H., Cao, Y., Liang, S., Wang, H., et al. (2016). Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid-induced rat autism model. International Journal of Developmental Neuroscience, 49, 67–78.
Khongrum, J., & Wattanathorn, J. (2015). Laser acupuncture improves behavioral disorders and brain oxidative stress status in the valproic acid rat model of autism. Journal of Acupuncture and Meridian Studies, 8(4), 183–191.
Ayyathan, D. M., Chandrasekaran, R., & Thiagarajan, K. (2015). Neuroprotective effect of Tagara, an Ayurvedic drug against methyl mercury induced oxidative stress using rat brain mitochondrial fractions. BMC Complementary and Alternative Medicine, 15, 268.
Zhang, Y., Yang, C., Yuan, G., Wang, Z., Cui, W., & Li, R. (2015). Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid. International Journal of Molecular Medicine, 35(1), 263–270.
Aldbass, A. M., Bhat, R. S., & El-Ansary, A. (2013). Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. Journal of Neuroinflammation, 27, 10–42.
Sandhya, T., Sowjanya, J., & Veeresh, B. (2012). Bacopa monnieri (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochemical Research, 37, 1121–1131.
Sadek, A., Berk, L. S., Mainess, K., & Daher, N. S. (2018). Antioxidants and autism: Teachers’ perceptions of behavioral changes. Advances in Mind-Body Medicine, 32(3), 12–17.
Bent, S., Lawton, B., Warren, T., Widjaja, F., Dang, K., Fahey, J. W., et al. (2018). Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Molecular Autism, 9, 35.
Mousavinejad, E., Ghaffari, M. A., Riahi, F., Hajmohammadi, M., Tiznobeyk, Z., & Mousavinejad, M. (2018). Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Research, 265, 62–69.
Nikoo, M., Radnia, H., Farokhnia, M., Mohammadi, M. R., & Akhondzadeh, S. (2015). N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: A randomized, double-blind, placebo-controlled clinical trial of efficacy and safety. Clinical Neuropharmacology, 38(1), 11–17.
Al-Ayadhi, L. Y., & Elamin, N. E. (2013). Camel milk as a potential therapy as an antioxidant in autism spectrum disorder (ASD). Evidence-based Complementary and Alternative Medicine, 2013, 602834.
Toroser, D., & Sohal, R. S. (2007). Age-associated perturbations in glutathione synthesis in mouse liver. The Biochemical Journal, 405(3), 583–589.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Manivasagam, T. et al. (2020). Role of Oxidative Stress and Antioxidants in Autism. In: Essa, M., Qoronfleh, M. (eds) Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Advances in Neurobiology, vol 24. Springer, Cham. https://doi.org/10.1007/978-3-030-30402-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-30402-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30401-0
Online ISBN: 978-3-030-30402-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)